Single Channel Pipetting Module Enables Hands-Free Transfers from Individual Tubes or Wells
By LabMedica International staff writers Posted on 01 Mar 2022 |

A new single channel pipetting module for hands-free transfers from individual tubes or wells effectively automates tedious tasks such as serial dilutions, sample normalization, hit picking or pipetting of complex plate layouts, thereby increasing productivity and reproducibility in the lab while reducing hands-on time, processing errors and physical strain.
INTEGRA Biosciences AG (Zizers, Switzerland) has launched the D-ONE single channel pipetting module to overcome the challenges of manually setting different pipetting volumes during sample normalization and missing wells during hit picking protocols. D-ONE allows the ASSIST PLUS pipetting robot to automatically perform individual sample transfers. The level of automation provided by the ASSIST PLUS pipetting robot has already hugely benefited routine pipetting tasks in labs around the world. It works with any of INTEGRA’s VIAFLO and VOYAGER electronic multichannel pipettes to offer up to 16 channel parallel pipetting, including adjustable tip spacing for convenient tube-to-plate transfers.
The D-ONE single channel pipetting module has been designed as a convenient and cost-effective solution enabling flexible, hands-free transfers from individual tubes or wells on the ASSIST PLUS. This novel solution offers researchers more versatility, enabling the rapid switching between single and multichannel pipetting to suit their application. This makes D-ONE the perfect add-on for labs that want to go beyond the possibilities of multichannel pipetting to access unlimited applications on the ASSIST PLUS. Tedious tasks such as normalizations, hit picking or pipetting of complex plate layouts can now be automated to ensure consistent and accurate results, eliminating transcription errors to simplify day-to-day activities and offer longer walk-away times.
The D-ONE single channel pipetting module has been carefully designed to meet the needs of most customer workflows, and is available in two volume ranges – from 0.5 to 300 μl and 5 to 1250 μl. To ensure optimal pipetting performance throughout the whole volume range, each D-ONE module has two separate pipetting channels, using 12.5 and 300 μl or 125 and 1250 μl GripTips for high and low volumes respectively. Combined with a specially designed D-ONE tip deck that can accommodate two tip racks, this allows the ASSIST PLUS to automatically select and switch between 12.5 and 300 µl or 125 and 1250 µl GripTips without tedious manual intervention. This enables the system to perform hands-free transfers from individual tubes or wells across a wide volume range, without compromising performance or needing to change the pipette tool during a protocol.
Automatic, real-time liquid level detection ensures aspiration is always performed at the optimal height for high precision pipetting results, regardless of the filling volume of each tube or well. The D-ONE pipetting module senses the liquid level immediately before aspiration, and is compatible with all INTEGRA GripTips used for benchtop pipetting devices. This avoids the need for special tips, and saves time during program set-up. The D-ONE single channel pipetting module allows straightforward automation of normalizations, hit picking and master mix preparation, as well as worry-free set-up of complex plate layouts. The intuitive VIALAB pipette automation software simplifies complex tasks such as normalization, automatically performing the required dilution calculations to equalize sample concentrations using varying volumes of diluent and sample in each well. The system also makes it easy to automate master mix preparation, combining varying volumes of buffers, primers and enzymes according to your desired number of samples. Alternatively, it can be effortlessly programmed using imported worklists to transfer samples from single wells to a target plate for hit picking applications, minimizing the risk of transcription errors.
Related Links:
INTEGRA Biosciences AG
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more